Panacea Venture

Summary

Panacea Venture is the famous VC, which was founded in 2017. The leading representative office of defined VC is situated in the Grand Cayman. The company was established in North America in Cayman Islands.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2019. Speaking about the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The typical startup value when the investment from Panacea Venture is 50-100 millions dollars. The fund is constantly included in 2-6 investment rounds annually.

Besides them, we counted 2 critical employees of this fund in our database.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. The fund has no specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Health Care, Biopharma. Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Oncologie, TriArm Therapeutics, Tactiva Therapeutics.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Panacea Venture, startups are often financed by Volcanics Venture, Redhill Capital, Pivotal bioVenture Partners China. The meaningful sponsors for the fund in investment in the same round are EFung Capital, Viventures, Virtus Inspire Ventures. In the next rounds fund is usually obtained by Innovate UK, Duchenne UK.